Amylyx Pharmaceuticals, Inc. ($AMLX)
Filing Information
| Accession Number | 0001193125-26-390509 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 14, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
10,810
Total Value
$349,820.67
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Sep 10, 2026 | Sale | 9,768 | $32.27 | $315,194.80 | 234,667 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Sep 10, 2026 | Sale | 1,042 | $33.23 | $34,625.87 | 233,625 | Direct | โ | View Details |